📰 Industry Classification Benchmark News
Page 5 - Industry Classification Benchmark News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Industry Classification Benchmark. Real-time updates on events, politics, business and more.
January 31, 2024
Motco grew its holdings in shares of iShares Biotechnology ETF (NASDAQ:IBB – Free Report) by 1.0% during the 3rd quarter, HoldingsChannel reports. The firm owned 56,485 shares of the financial services provider’s stock after buying an additional 537 shares during the period. Motco’s holdings in iShares Biotechnology ETF were worth $6,908,000 at the end of […]
January 31, 2024
Motco grew its holdings in shares of iShares Biotechnology ETF (NASDAQ:IBB – Free Report) by 1.0% during the third quarter, Holdings Channel reports. The firm owned 56,485 shares of the financial services provider’s stock after purchasing an additional 537 shares during the quarter. Motco’s holdings in iShares Biotechnology ETF were worth $6,908,000 at the end […]
January 31, 2024
Motco grew its position in iShares Biotechnology ETF (NASDAQ:IBB – Free Report) by 1.0% during the 3rd quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The firm owned 56,485 shares of the financial services provider’s stock after acquiring an additional 537 shares during the quarter. Motco owned […]
January 31, 2024
Adell Harriman & Carpenter Inc. trimmed its stake in iShares Biotechnology ETF (NASDAQ:IBB – Free Report) by 2.1% in the third quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 10,967 shares of the financial services provider’s stock after selling 230 shares during the […]
January 28, 2024
NBC Securities Inc. bought a new position in shares of iShares Biotechnology ETF (NASDAQ:IBB – Free Report) during the 3rd quarter, according to the company in its most recent Form 13F filing with the SEC. The institutional investor bought 5,137 shares of the financial services provider’s stock, valued at approximately $628,000. Several other hedge funds […]
January 28, 2024
Empower Advisory Group LLC lessened its stake in shares of iShares Biotechnology ETF (NASDAQ:IBB – Free Report) by 5.1% in the 3rd quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The fund owned 1,744 shares of the financial services provider’s stock after selling 94 shares during the period. Empower […]
January 24, 2024
Column Capital Advisors LLC purchased a new stake in iShares Biotechnology ETF (NASDAQ:IBB – Free Report) in the 3rd quarter, Holdings Channel.com reports. The institutional investor purchased 401 shares of the financial services provider’s stock, valued at approximately $49,000. Several other institutional investors have also added to or reduced their stakes in the company. Leo […]
January 24, 2024
Pacific Capital Wealth Advisors Inc. lessened its holdings in shares of iShares Biotechnology ETF (NASDAQ:IBB – Free Report) by 8.8% during the third quarter, according to the company in its most recent Form 13F filing with the SEC. The firm owned 63,695 shares of the financial services provider’s stock after selling 6,121 shares during the […]
January 24, 2024
Pacific Capital Wealth Advisors Inc. reduced its stake in shares of iShares Biotechnology ETF (NASDAQ:IBB – Free Report) by 8.8% in the 3rd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 63,695 shares of the financial services provider’s stock after selling 6,121 […]
January 23, 2024
Blume Capital Management Inc. lowered its holdings in iShares Biotechnology ETF (NASDAQ:IBB – Free Report) by 1.6% in the third quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The firm owned 53,551 shares of the financial services provider’s stock after selling 867 shares during the period. iShares Biotechnology ETF […]